论文部分内容阅读
目的探讨阿托伐他汀治疗肾病综合征高脂血症临床效果。方法我院治疗的肾病综合征高脂血症患者90例,随机分为治疗组和对照组各45例。两组患者均给予泼尼松治疗,治疗组在此基础上加用阿托伐他汀钙片口服治疗。结果治疗后,两组患者的血脂均较治疗前有明显的改善,差异有统计学意义(P<0.05),而治疗后,治疗组患者的血脂水平明显优于对照组患者,差异有统计学意义(P<0.05)。结论阿托伐他汀治疗肾病综合征高脂血症具有疗效确切,无不良反应的特点,值得临床推广使用。
Objective To investigate the clinical effect of atorvastatin in the treatment of nephrotic syndrome and hyperlipidemia. Methods 90 cases of nephrotic syndrome patients with hyperlipidemia were randomly divided into treatment group and control group of 45 cases. Both groups were given prednisone treatment, the treatment group on the basis of plus atorvastatin calcium tablets oral treatment. Results After treatment, the blood lipids in both groups were significantly improved compared with those before treatment (P <0.05), and the levels of blood lipids in the treatment group were significantly better than those in the control group after treatment Significance (P <0.05). Conclusion Atorvastatin treatment of nephrotic syndrome with hyperlipidemia with exact efficacy, no adverse reactions, it is worth promoting the use of the clinic.